Towards the development of new nucleic acid medicines for the prevention of locomotor disorders and metabolic syndrome!
Oligo DNA derived from the genomic sequences of beneficial microorganisms such as lactic acid bacteria forms a characteristic three-dimensional structure and functions as an aptamer that binds to target proteins. Muscle-forming type oligo DNA promotes muscle differentiation, enhances cardiomyocyte differentiation, and suppresses adipocyte differentiation, while bone-forming type oligo DNA promotes the differentiation of osteoblasts.
Inquire About This Product
basic information
Patent applications filed: [Application No. 2018-568609, Application No. 2019-142724, Application No. 2018-142473, Application No. 2020-125833, Application No. 2020-126866]
Price range
Delivery Time
Applications/Examples of results
- Pharmaceuticals and supplements aimed at the prevention and treatment of locomotive syndrome (such as sarcopenia and osteoporosis) - Pharmaceuticals and supplements aimed at the prevention and treatment of metabolic syndrome (such as obesity and arteriosclerosis) - Reagents used in basic research for stem cells and regenerative medicine
Company information
Since our establishment, we have been supporting the commercialization of various companies. We have extensive experience and achievements in commercializing technologies developed at universities and launching new businesses utilizing subsidies. We will introduce researchers and technology seeds suitable for your company's products, technology development, and research. Please feel free to contact us.